Should Oncologists Be Aware in Their Clinical Practice of KRAS Molecular Analysis?

被引:16
作者
Santini, Daniele [1 ]
Galluzzo, Sara [1 ]
Gaeta, Laura [1 ]
Zoccoli, Alice [1 ]
Riva, Elisabetta [1 ]
Ruzzo, Annamaria [2 ]
Vincenzi, Bruno [1 ]
Graziano, Francesco [3 ]
Loupakis, Fotios [4 ]
Falcone, Alfredo [4 ]
Muda, Andrea Onetti [1 ]
Tonini, Giuseppe [1 ]
机构
[1] Univ Campus Biomed, Rome, Italy
[2] Univ Urbino, Inst Biochem G Fornaini, I-61029 Urbino, Italy
[3] Azienda Osped Osped San Salvatore, Pesaro, Italy
[4] Azienda Osped Univ Pisana, Pisa, Italy
关键词
MUTATIONS;
D O I
10.1200/JCO.2010.32.7700
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E206 / E207
页数:2
相关论文
共 6 条
[1]   American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy [J].
Allegra, Carmen J. ;
Jessup, J. Milburn ;
Somerfield, Mark R. ;
Hamilton, Stanley R. ;
Hammond, Elizabeth H. ;
Hayes, Daniel F. ;
McAllister, Pamela K. ;
Morton, Roscoe F. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2091-2096
[2]  
FREEMAN DJ, 1998, SCIENCE, V281, P363
[3]   KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer [J].
Lièvre, A ;
Bachet, JB ;
Le Corre, D ;
Boige, V ;
Landi, B ;
Emile, JF ;
Côté, JF ;
Tomasic, G ;
Penna, C ;
Ducreux, M ;
Rougier, P ;
Penault-Llorca, F ;
Laurent-Puig, P .
CANCER RESEARCH, 2006, 66 (08) :3992-3995
[4]   KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J].
Lievre, Astrid ;
Bachet, Jean-Baptiste ;
Boige, Valerie ;
Cayre, Anne ;
Le Corre, Delphine ;
Buc, Emmanuel ;
Ychou, Marc ;
Bouche, Olivier ;
Landi, Bruno ;
Louvet, Christophe ;
Andre, Thierry ;
Bibeau, Frederic ;
Diebold, Marie-Daniele ;
Rougier, Philippe ;
Ducreux, Michel ;
Tomasic, Gorana ;
Emile, Jean-Francois ;
Penault-Llorca, Frederique ;
Laurent-Puig, Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :374-379
[5]   Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations Diagnostic and Clinical Implications [J].
Tsiatis, Athanasios C. ;
Norris-Kirby, Alexis ;
Rich, Roy G. ;
Hafez, Michael J. ;
Gocke, Christopher D. ;
Eshleman, James R. ;
Murphy, Kathleen M. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (04) :425-432
[6]   KRAS Mutation Testing in Human Cancers: The Pathologist's Role in the Era of Personalized Medicine [J].
Wang, Hanlin L. ;
Lopategui, Jean ;
Amin, Mahul B. ;
Patterson, Scott D. .
ADVANCES IN ANATOMIC PATHOLOGY, 2010, 17 (01) :23-32